N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial.
about
N-acetylcysteine for sepsis and systemic inflammatory response in adultsGlucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malariaTempol, an intracellular antioxidant, inhibits tissue factor expression, attenuates dendritic cell function, and is partially protective in a murine model of cerebral malaria.Role of Coma Acidosis Malaria Score in Patients with Severe Malaria among Indian Population: a Tertiary Care Center Experience.Cell-free hemoglobin mediated oxidative stress is associated with acute kidney injury and renal replacement therapy in severe falciparum malaria: an observational study.Oscillations in cerebral haemodynamics in patients with falciparum malaria.Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malariaManaging malaria in the intensive care unit.Investigation of hydrogen sulfide gas as a treatment against P. falciparum, murine cerebral malaria, and the importance of thiolation state in the development of cerebral malaria.Lipoxin A₄ and 15-epi-lipoxin A₄ protect against experimental cerebral malaria by inhibiting IL-12/IFN-γ in the brainThe plant-based immunomodulator curcumin as a potential candidate for the development of an adjunctive therapy for cerebral malariaA simple score to predict the outcome of severe malaria in adults.Management of severe paediatric malaria in resource-limited settings.Impaired systemic tetrahydrobiopterin bioavailability and increased dihydrobiopterin in adult falciparum malaria: association with disease severity, impaired microvascular function and increased endothelial activation.Laboratory prediction of the requirement for renal replacement in acute falciparum malaria.The role of previously unmeasured organic acids in the pathogenesis of severe malaria.Methemoglobin and nitric oxide therapy in Ugandan children hospitalized for febrile illness: results from a prospective cohort study and randomized double-blind placebo-controlled trial.Cytoadherence and severe malaria.Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum MalariaThe global pipeline of new medicines for the control and elimination of malariaA new hypothesis on the manifestation of cerebral malaria: the secret is in the liverRandomized controlled trial of levamisole hydrochloride as adjunctive therapy in severe falciparum malaria with high parasitemia.Rapid clinical assessment to facilitate the triage of adults with falciparum malaria, a retrospective analysis.Correlation of biomarkers for parasite burden and immune activation with acute kidney injury in severe falciparum malariaOxidative and nitrosative stress on phagocytes' function: from effective defense to immunity evasion mechanisms.The role of antioxidants treatment on the pathogenesis of malarial infections: a review.The immunological balance between host and parasite in malaria.Cerebral malaria--clinical manifestations and pathogenesis.Autoprocessing of human immunodeficiency virus type 1 protease miniprecursor fusions in mammalian cells.Antioxidant therapy: reducing malaria severity?Extracellular methemoglobin primes red blood cell aggregation in malaria: an in vitro mechanistic study.Adjunctive therapy for severe malaria: a review and critical appraisal.Persistent cognitive impairment after cerebral malaria: models, mechanisms and adjunctive therapies.The effect of regularly dosed paracetamol versus no paracetamol on renal function in Plasmodium knowlesi malaria (PACKNOW): study protocol for a randomised controlled trial.Acidosis and acute kidney injury in severe malaria.
P2860
Q24200340-3BB34C56-8E93-48FD-A466-C3ABA64DBD9EQ28597322-3629E7E1-F75F-4535-BBF5-3B640021AEBBQ30457536-554AC22F-8FAA-4B82-A5FE-29AC09D1C835Q33557414-CE4FC58F-5586-4B0D-A925-5E35EFE1AC3CQ33612718-BB20F377-9756-420C-B29F-8A31471C2F22Q33683727-8E5B7A8E-01A9-4E67-9368-FA264AA1975EQ34328743-D33C0191-2FDE-4FCA-8106-FAF0A510B99EQ34532597-CC97E999-B4E7-4338-A146-5F826B1FDEDEQ34650997-5EF2C5D7-99E3-4F3E-911F-3CF9F7511979Q34685370-1BAFA1B2-A770-4883-A03F-D2654204A74AQ34687796-79B5BA8D-6070-4DA3-89CE-8A9DEFC3F273Q35036422-35B1BB8B-644B-4CA6-B197-494C30DA156DQ35142564-00AA8D67-6343-4E71-99A6-654EB16551F7Q35170674-9E7EFE25-EEC2-4D11-9951-85FCF8E3A165Q35428615-B83D06D1-423A-48E0-BD28-C91807CCAFCBQ36032306-8BD32D94-343F-4B0C-AD29-A029AD4609CBQ36183209-314BC5B0-0D91-4301-8631-6F2EA33CFC06Q36202059-AB1A6BDD-CA61-4FBC-9366-84B8016677A8Q36239480-7E95C8C1-852D-449A-9FB0-FD47E35A55ADQ36320249-5F9C797D-AB5E-4336-BF11-DC33CE48C4C7Q37281876-FE0DE155-F70E-4A9D-9025-F153C81A76A3Q37395313-E4BAD85D-5B3A-4757-B1B8-0B64FB6E5011Q37529508-8C33CEEF-09AD-4EC3-A6CD-ACBD4D391228Q37716666-28E5DD79-43E8-4EB3-9FD4-4EA715A804BAQ37942503-CADFB587-CB7A-40AF-85A8-B36C6C0761A0Q38187860-B27872E2-2016-47C3-937F-F69C83BC93BAQ38666558-5AC6B4E6-398A-4D61-B434-4BF0C884265EQ38690668-B5ADFD61-007D-4EA2-866D-862F85264B93Q41958450-13A4D522-F3EF-43E4-9108-9C4E0C3A06B2Q42956703-5D8F792D-2E82-43E1-ADF7-389DEDB26F7FQ44322869-871925C6-A859-461B-A3AB-EC83BE576F9FQ47716363-09038A05-B5A9-4485-A98D-F9413C4111EDQ47965516-BFFA877C-A7B4-4FF2-9EBF-4D6D5766C7EEQ52716988-CFD02D55-05F6-474C-9EF1-4F915B896F43Q55236140-3D2E4297-ABC5-4FAB-9B85-717649DDC9BF
P2860
N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
N-acetylcysteine as adjunctive ...... ebo-controlled clinical trial.
@en
N-acetylcysteine as adjunctive ...... ebo-controlled clinical trial.
@nl
type
label
N-acetylcysteine as adjunctive ...... ebo-controlled clinical trial.
@en
N-acetylcysteine as adjunctive ...... ebo-controlled clinical trial.
@nl
prefLabel
N-acetylcysteine as adjunctive ...... ebo-controlled clinical trial.
@en
N-acetylcysteine as adjunctive ...... ebo-controlled clinical trial.
@nl
P2093
P2860
P50
P1476
N-acetylcysteine as adjunctive ...... ebo-controlled clinical trial.
@en
P2093
Emran Bin Yunus
Kevin Moore
L Jackson Roberts
M Abul Faiz
M Gofranul Hoque
M Ridwanur Rahman
Mahatab Uddin Hasan
Paul N Newton
Prakaykaew Charunwatthana
Richard J Maude
P2860
P304
P356
10.1097/CCM.0B013E3181958DFD
P407
P577
2009-02-01T00:00:00Z